Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0268318 (
ICP
)
10,007
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A novel 3D copper-phosphonate network, with the general formula Cu
7
(H
1
L)
2
(TPT)
3
(H
2
O)
6
, namely compound 1, has been synthesized using a rigid tetrahedral linker
tetraphenylsilane
tetrakis-4-phosphonic acid (H
8
L) and a nitrogen-containing ancillary ligand (TPT: [5-(4-(1H-1,2,4-triazol-1-yl)phenyl)-1H-tetrazole]) under hydrothermal conditions. The compound was fully characterized using PXRD,
ICP
, IR, TGA and elemental analysis. Compound 1 can be used as an efficient catalyst for the CO
2
coupling reaction that is greatly superior to many conventional MOF-based catalysts, where porosity is always mentioned and used. In addition, it shows excellent catalytic performance for ring-opening reactions with epoxides under ambient conditions. Additionally, compound 1 can be recycled at least three times without a significant compromise in the activity in the two catalytic reactions.
...
PMID:A copper-phosphonate network as a high-performance heterogeneous catalyst for the CO
2
cycloaddition reactions and alcoholysis of epoxides. 2848
